About this project

About Melanotan 2 Rx

Who publishes this digest, what it is, and what it deliberately is not.

What this site is

Melanotan 2 Rx is an independent editorial project that publishes plain-English summaries of the peer-reviewed research literature on Melanotan 2. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

We started this project because the public conversation about Melanotan 2 is dominated by marketing and forum lore on one side and brief regulator warnings on the other, with the actual studies rarely read. Our aim is to put the published evidence — the strong animal data, the small old human trials, and the case reports of harm — in one accessible, fully cited place.

About the name

The 'Rx' in our name is editorial framing, not a claim about services. It signals our angle on the literature — a focus on how this compound has been studied and discussed in a clinical and pharmacological frame — not that we prescribe, dispense, or offer any medical service. We do none of those things. Melanotan 2 is not an approved medicine in any country, and nothing on this site should be read as a prescription, a protocol, or an endorsement of using it.

How we work

Every quantitative claim on this site — every dose, percentage, duration, and study result — is tied to a specific source listed on the references page, with a link to its PubMed record. We describe what experiments measured, in which species, at which doses, without translating any of it into instructions for people. We distinguish clearly between controlled findings, animal data, individual case reports, and anecdotal community reports. When the evidence is thin or absent, we say so plainly rather than filling the gap with speculation.